You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Home Clinical Information Performance Measures Cervical Cancer Screening

Cervical Cancer Screening

    Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:

    • Women age 21-64 who had cervical cytology performed every 3 years.
    • Women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every 5 years.
    Date Reviewed: November 17, 2017
    Support
    Health Plan Integrated Delivery System

    Measure Info

    MIPS 309NQF 0032CMS 309NQF EndorsedCQMC Core Measure
    Measure Type: 
    Process
    Measure Steward: 
    National Committee for Quality Assurance
    Clinical Topic Area: 
    Cancer Screening
    Prevention and Wellness
    Women's Preventive Services
    Care Setting: 
    Clinician Office/Clinic
    Data Source: 
    Administrative Claims
    Electronic Health Records
    Paper Medical Records

    ACP supports QPP measure 309: "Cervical Cancer Screening" because the current evidence supports screening in women 21-64 years of age and this measure is based on the most recent United States Preventive Services Task Force recommendations on cervical cancer screening.

    As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!